Atlas Trials

Safety Study of Afatinib for Brain Cancer

Clinical trial NCT02423525 · COMPLETED

Trial details

NCT number
NCT02423525
Sponsor
Santosh Kesari
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Brain Cancer
Start date
2016-12-01
Primary completion
2020-08-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.